Drugs and Devices Division
EO Decisions and CED Recommendations
The information below is intended only to provide the recommendations and rationale from the Committee to Evaluate Drugs (CED) and the Executive Officer decisions regarding the listing of products on the Formulary, funding of cancer drugs through the New Drug Funding Program, funding through the Exceptional Access Program, or funding through the Special Drugs Program.
For further details on what types of information is provided, please refer to the Transparency of the Drug Review Process.
Do not rely upon any of the information provided on this site for medical diagnosis or treatment. Please consult your primary health care provider about any personal health concerns. This website does not provide any medical diagnosis, symptom assessment, health counseling or medical opinion for individual users. The information contained on this site is intended for information purposes only and does not constitute medical advice for patients. For more detailed information on prescription drugs, please consult a qualified healthcare professional.
| Brand Name | Generic Name |
|---|---|
| January 2016 | |
| Adcetris for systemic anaplastic large cell lymphoma | brentuximab |
| Afinitor for renal angiomyolipoma associated with tuberous sclerosis complex | everolimus |
| Alimta for maintenance treatment of non-small cell lung cancer | pemetrexed |
| Actemra for juvenile arthritis | tocilizumab |
| Bystolic | nebivolol |
| Cubicin | daptomycin |
| Edarbi | azilsartan medoxomil |
| Edarbyclor | azilsartan medoxomil / chlorthalidone |
| Erivedge | vismodegib |
| Giotrif | afatinib |
| Inspra for heart failure | eplerenone |
| Jetrea | ocriplasmin |
| Kadcycla | trastuzumab emtansine |
| Latuda for schizophrenia | lurasidone hydrochloride |
| Stivarga for gastrointestinal stromal tumours | regorafenib |
| Stivarga for metastatic colorectal cancer | regorafenib |
| Tafinlar | dabrafenib |
| TOBI Podhaler | tobramycin inhalation powder |
| Tudorza Genuair | aclidinium |
| Xarelto for pulmonary embolism | rivaroxaban |
| May 2015 | |
| Adcetris - Hodgkin lymphoma | brentuximab |
| Androderm 24.3 mg transdermal patch | testosterone |
| Caripul | epoprostenol |
| Clindoxyl ADV Gel | clindamycin 1%/ benzoyl peroxide 3% |
| Dovobet gel | calcipotriol / betamethasone |
| Epuris | isotretinoin |
| Esbriet | pirfenidone |
| Fycompa | perampanel |
| Genotropin | somatropin |
| Jentadueto | linagliptin / metformin |
| Mekinist | trametinib |
| Nutropin AQ® NuSpin® 5 and 20 | somatropin |
| Pentasa 1 gram extended-release tablet | 5-aminosalicylic acid |
| Perjeta | pertuzumab / trastuzumab |
| Picato | ingenol mebutate topical gel |
| Revlimid | lenalidomide |
| Samsca | tolvaptan |
| Sublinox | zolpidem |
| Tecfidera | dimethyl fumarate |
| Trisenox | arsenic trioxide |
| Votrient | pazopanib |
| Zytiga | abiraterone |
| January 2014 | |
| Avastin – GBM re-evaluation | bevacizumab |
| November 2012 | |
| Champix | varenicline |
| March 2012 | |
| Januvia | sitagliptin |
| October 2011 | |
| Avastin – GBM | bevacizumab |
| Fludara – CLL | fludarabine tablet |
| Metvix | methyl aminolevulinate |
| Rituxan – CLL | rituximab |
| May 2011 | |
| Adcirca | tadalafil |
| Afinitor | everolimus |
| Orencia | abatacept |
| Torisel | temsirolimus |
| Vidaza | azacitidine |
| April 2011 | |
| Erbitux – head & neck cancer | cetuximab |
| Erbitux – metastatic colorectal cancer | cetuximab |
| Prolastin | alpha1-proteinase inhibitor |
| Simponi – ankylosing spondylitis | golimumab |
| Simponi – psoriatic arthritis | golimumab |
| Simponi – rheumatoid arthritis | golimumab |
| February 2011 | |
| Tysabri | natalizumab |
| January 2011 | |
| Gleevec – ALL | imatinib |
| Long-Acting medications for Attention Deficit Hyperactivity Disorder (ADHD) | long-acting medications for attention deficit hyperactivity disorder (ADHD) |
| Sprycel – ALL | dasatinib |
| Thelin | sitaxsentan |
| November 2010 | |
| Leukotriene Receptor Antagonists (Singulair, Accolate) |
leukotriene receptor antagonists (montelukast, zafirlukast) |
| August 2010 | |
| Levemir Penfill | insulin detemir |
| Lantus SoloStar | insulin glargine |
| Humalog Mix50 | insulin lispro/insulin lispro protamine |
| Cymbalta for DPN | duloxetine for DPN |
| Azilect | rasagiline |
| July 2010 | |
| Actonel 75mg and 150mg | risedronate sodium |
| Combination treatment for Pulmonary Arterial Hypertension (PAH) | |
| Fosavance 70/140 | alendronate-cholecalciferol |
| Revatio | sildenafil |
| Volibris | ambrisentan |
| June 2010 | |
| Seroquel XR | quetiapine fumarate |
| Mezavant | mesalamine (5-ASA) |
| Ralivia | tramadol hydrochloride ER |
| Tridural | tramadol hydrochloride ER |
| Zytram XL | tramadol hydrochloride XL |
| Xarelto | rivaroxaban |
| April 2010 | |
| Advagraf | tacrolimus (extended-release) |
| Abraxane | nab-paclitaxel |
| Resultz | isopropyl myristate |
| Faslodex | fulvestrant |
| March 2010 | |
| Exjade | deferasirox |
| Kaletra pediatric tablet | lopinavir / ritonavir |
| February 2010 | |
| Aldara | imiquimod |
| Atacand | candesarten cilexetil |
| Biphentin | methylphenidate extended release |
| Fluanxol Depot | flupenthixol decanoate |
| Nuvaring | etonogestrel / ethinyl estradiol |
| Rebif initiation package | interferon beta1a |
| Vantas | histrelin acetate |
| December 2009 | |
| Myozyme | alglucosidase alfa |
| November 2009 | |
| Cubicin | daptomycin |
| Eprex - additional dosage forms | epoetin alfa - additional dosage forms |
| Invega | paliperidone |
| Omnaris | ciclesonide |
| One-Alpha | alfacalcidol |
| October 2009 | |
| Adderall XR | mixed amphetamine salts |
| Celsentri | maraviroc |
| Cosopt Preservative Free | dorzolamide/timolol |
| Diovan-HCT | valsartan/ hydrochlorothiazide |
| Exelon Patch | rivastigmine patch |
| Rasilez | aliskiren |
| Stalevo | levodopa/ carbidopa/ entacapone |
| Xeloda | capecitabine (as component of CAPOX regimen) |
| September 2009 | |
| Avastin - for metastatic colorectal cancer | bevacizumab |
| Elaprase | idursulfase |
| April 2009 | |
| Posanol | posaconazole |
| Revlimid – myelodysplastic syndrome | lenalidomide |
| Seasonale | levonorgestrel / ethinyl estradiol |
| March 2009 | |
| Intelence | etravirine |
| Lantus | insulin glargine |
| February 2009 | |
| Hyzaar | losartan/hydrochlorothiazide |
| Vectibix | panitumumab |
| January 2008 | |
| Aclasta – osteoporosis | zoledronic acid |
| Nexavar – hepatocellular carcinoma | sorafenib |
| Rituxan – rheumatoid arthritis | rituximab |
| December 2008 | |
| Levaquin 750mg | levofloxacin |
| Sensipar | cinacalcet |
| Sprycel – chronic myeloid leukemia | dasatinib |
| November 2008 | |
| Cipralex | escitalopram |
| Combigan 10mL – new package size | brimonidine/timolol |
| October 2008 | |
| Dovobet | calcipotriol/betamethasone |
| Eloxatin – adjuvant treatment of colorectal cancer | oxaliplatin |
| Eloxatin – metastatic colorectal cancer | oxaliplatin |
| Nexavar – metastatic renal cell carcinoma | sorafenib |
| August 2008 | |
| Alimta – non-small cell lung cancer | pemetrexed |
| Aromasin – early breast cancer | exemestane |
| Gemzar – metastatic breast cancer | gemcitabine hydrochloride |
| Hycamtin – small cell lung cancer | topotecan |
| Kaletra | lopinavir/ritonavir |
| MabCampath | alemtuzumab |
| Trosec | trospium chloride |
| Xeloda – gastric cancer | capecitabine |
| June 2008 | |
| Altace HCT | ramipril/hydrochlorothiazide |
| Aricept RDT | donepezil rapidly dissolving tablet |
| Denavir | penciclovir |
| Exjade | deferasirox |
| Lucentis | ranibizumab |
| Truvada | emtricitabine/tenofovir disoproxil fumarate |
| May 2008 | |
| Alvesco | ciclesonide |
| DDAVP Melt | desmopressin |
| Elaprase | idursulfase |
| Hypurin | insulin porcine |
| Sutent – MRCC | sunitinib |
| January 2008 | |
| Prezista | darunavir |
| Linessa | desogestrel/ethinyl estradiol |
| Yasmin | drospirenone/ethinyl estradiol |
| Femara | letrozole |
| Altace 15mg capsule | ramipril 15mg capsule |
| October 2007 | |
| Duragesic 12 | fentanyl 12.5mcg/hr transdermal patch |
| Altace Plus Felodipine | ramipril/felodipine |
| Avalide | irbesartan/hydrochlorothiazide |
| Caelyx – recurrent ovarian cancer | pegylated liposomal doxorubicin |
| Humira – psoriatic arthritis | adalimumab |
| Hycamtin – recurrent ovarian cancer | topotecan |
| Sutent – GIST | sunitinib |
| Taxol – recurrent ovarian cancer | paclitaxel |
| Vfend | voriconazole |
| July 2007 | |
| Actonel Plus Calcium | risedronate sodium/calcium carbonate |
| Alimta - MPM | pemetrexed |
| Diovan | valsartan |
| Enablex | darifenacin |
| Fosavance | alendronate/cholecalciferol |
| Gleevec - CML | imatinib mesylate |
| Gleevec - GIST | imatinib mesylate |
| OxyContin | oxycodone hydrochloride |
Public Information
